Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Olmesartan medoxomil tablets
DRUG
2 trials
Sponsors
Chinese PLA General Hospital
, Lee's Pharmaceutical Limited
Conditions
Coronary Atherosclerosis
Hypertension
Phase 3
Azilsartan in Chinese Patients With Mild and Moderate Hypertension
Completed
NCT02609490
Lee's Pharmaceutical Limited
Hypertension
Start: 2015-09-30
End: 2018-08-31
Updated: 2018-09-04
Phase 4
Efficacy Study of Olmesartan Medoxomil on Coronary Atherosclerosis and Epicardial Adipose Tissue(EAT)
NCT02360956
Chinese PLA General Hospital
Coronary Atherosclerosis
Start: 2014-12-31
End: 2016-06-30
Target: 100
Updated: 2015-02-11
Related Papers
Efficacy study of olmesartan medoxomil on coronary atherosclerosis progression and epicardial adipose tissue volume reduction in patients with coronary atherosclerosis detected by coronary computed tomography angiography: study protocol for a randomized controlled trial.
2016-01-06
4 citations